RESUMEN
PURPOSE: Epidemiological evidence regarding the radiosensitivity of the lens of the eye and radiation cataract development has led to changes in the EU Basic Safety Standards for protection of the lens against ionizing radiation. However, mechanistic details of lens radiation response pathways and their significance for cataractogenesis remain unclear. Radiation-induced DNA damage and the potential impairment of repair pathways within the lens epithelium, a cell monolayer that covers the anterior hemisphere of the lens, are likely to be involved. MATERIALS AND METHODS: In this work, the lens epithelium has been analyzed for its DNA double-strand break (DSB) repair response to ionizing radiation. The responses of epithelial cells located at the anterior pole (central region) have been compared to at the very periphery of the monolayer (germinative and transitional zones). Described here are the different responses in the two regions and across four strains (C57BL/6, 129S2, BALB/c and CBA/Ca) over a low dose (0-25 mGy) in-vivo whole body X-irradiation range up to 24 hours post exposure. RESULTS: DNA damage and repair as visualized through 53BP1 staining was present across the lens epithelium, although repair kinetics appeared non-uniform. Epithelial cells in the central region have significantly more 53BP1 foci. The sensitivities of different mouse strains have also been compared. CONCLUSIONS: 129S2 and BALB/c showed higher levels of DNA damage, with BALB/c showing significantly less inter-individual variability and appearing to be a more robust model for future DNA damage and repair studies. As a result of this study, BALB/c was identified as a suitable radiosensitive lens strain to detect and quantify early low dose ionizing radiation DNA damage effects in the mouse eye lens specifically, as an indicator of cataract formation.
Asunto(s)
Daño del ADN , Cristalino/metabolismo , Cristalino/efectos de la radiación , Animales , Reparación del ADN/efectos de la radiación , Relación Dosis-Respuesta en la Radiación , Epitelio/metabolismo , Epitelio/efectos de la radiación , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Tolerancia a Radiación/genética , Especificidad de la Especie , Factores de TiempoRESUMEN
PURPOSE: To assess the sensitivity of ApcMin/+ mice (adenomatous polyposis coli Apc, multiple intestinal neoplasia, Min) to the development of intestinal adenomas after x-irradiation in utero, as neonates, or as young adults. MATERIALS AND METHODS: CHB6 ApcMin/+ mice were exposed to an acute dose of 2 Gy x-rays either in utero on day 7 or 14 post-conception, as 2-day or 10-day neonates or as 35-day young adults. Tumour identification and counting was performed 200-214 days later. RESULTS: Irradiation as 10-day-old neonates resulted in a significantly greater overall tumour incidence (average of about 130 tumours per animal) than irradiation as 35-day-old young adults (about 70 tumours). Irradiation as 2-day-old neonates resulted in an intermediate incidence (about 85 tumours). In contrast, the greatest tumour incidence observed after in utero irradiation of ApcMin/+ mice, of about 44 tumours per animal after 2 Gy irradiation at 14 days post-conception, was significantly lower than the incidence in irradiated adults. Tumour incidences after irradiation as 7-day embryos was not significantly raised above numbers in unirradiated controls (about 30 tumours). These tumour numbers include cystic crypts, largely radiation-induced, which were classed as early stage microadenomas on the basis of loss of wild-type Apc+ and expression of beta-catenin. CONCLUSIONS: The sensitivity of ApcMin/+ mice to the induction of intestinal tumours by radiation was shown to be in the order: 10 d neonates>2 d neonates>35 d young adults>14 d fetus>7 d embryo.
Asunto(s)
Feto/efectos de la radiación , Genes APC/fisiología , Neoplasias Intestinales/etiología , Neoplasias Inducidas por Radiación/etiología , Factores de Edad , Animales , Animales Recién Nacidos , Reparación del ADN , Ratones , Proteínas del Tejido Nervioso/análisis , Proteínas de Unión al ARN/análisisRESUMEN
Hamsters were exposed to an aerosol of fused aluminosilicate particles (FAP) labeled with 57Co. Three groups of animals were given bronchopulmonary lavage, beginning at either 1 week, 1 month, or 6 months after exposure. Each treated group was lavaged eight times over a period of 25 days. Each lavage involved 10 saline washes of the lungs. For each group, about 60-70% of the body content of 57Co at the start of lavage treatment was removed; nearly half of this was recovered in the first two lavages. A positive correlation was demonstrated between the macrophage content and 57Co activity of the washings. The subsequent fractional clearance rate of 57Co from lavaged animals was not significantly different from that in a group of untreated control animals.
Asunto(s)
Silicatos de Aluminio/farmacocinética , Pulmón/metabolismo , Pulmón/fisiología , Macrófagos/citología , Irrigación Terapéutica , Aerosoles , Animales , Líquido del Lavado Bronquioalveolar/citología , Recuento de Células , Radioisótopos de Cobalto , Cricetinae , Inhalación , Masculino , Factores de TiempoRESUMEN
The microdistributions of the alpha-particle-emitting bone surface-seeking radionuclides (239)Pu, (241)Am and (233)U in the mouse femoral shaft have been studied using computer-based image analysis of neutron-induced and alpha-particle track autoradiographs, prepared from femora of CBA/H mice which had been injected with 40 kBq kg(-1) of radionuclide (as citrate solution) at times from 1 to 448 days previously. Employing dosimetric methods, radiation dose rates and cumulative radiation doses to regions of the bone marrow thought to contain hemopoietic and stromal progenitor cells susceptible to neoplastic transformation to leukemia and osteosarcomas have been calculated. It has been shown that the three radionuclides differ in their relative deposition on the bone surfaces, and that patterns of changing redistribution with time are also varied. For stromal progenitor cells, which are thought to be targets for induction of osteosarcoma and are found in proximity to the bone surfaces, cumulative doses showed the trend (239)Pu > (241)Am > (233)U, correlating well with incidences of osteosarcoma observed in mice. Cumulative doses to the primitive hemopoietic stem cells, concentrated in the central marrow and thought to be susceptible to neoplastic transformation to myeloid leukemia, were considerably lower and also showed the trend plutonium > americium > uranium.
Asunto(s)
Partículas alfa/efectos adversos , Médula Ósea/efectos de la radiación , Huesos/efectos de la radiación , Células Madre Hematopoyéticas/efectos de la radiación , Animales , Autorradiografía , Femenino , Macrófagos/efectos de la radiación , Masculino , Ratones , Ratones Endogámicos DBA , Dosis de Radiación , Células del Estroma/efectos de la radiaciónRESUMEN
PURPOSE: To compare tumour induction in CBA/H mice, principally osteosarcoma and acute myeloid leukaemia, resulting from exposure to the alpha-emitting nuclides, uranium-233, plutonium-239 and americium-241, and to relate differences between the three nuclides to the pattern of dose delivery within tissues. MATERIALS AND METHODS: Each nuclide was administered intraperitoneally in citrate solution to three groups of adult male CBA/H mice at levels of activity which gave estimated life-time average skeletal doses of about 0.25-0.3 Gy, 0.5-1 Gy and 1-2 Gy. Animals were carefully monitored and sacrificed as soon as they showed signs of ill health; tumours were identified by standard histopathological techniques. RESULTS: Statistical modelling by Cox regression showed that, considering all three nuclides together, there was a highly significant increase in risk of death from osteosarcoma or myeloid leukaemia with increasing dose rate. For osteosarcoma, the effect was significantly greater for 239Pu than 241Am, while separate analysis for 233U showed no significant increase with increasing dose rate. For example, the increase in relative risk of death from osteosarcoma for an increase in life-time average dose rate to bone of 1 mGyd(-1) was 4.2 (2.7-6.5) for 239Pu, 2.3 (1.4-3.4) for 241Am and 1.1 (0.4-3.1) for 233U. For myeloid leukaemia, there was no significant difference between 239Pu and 241Am in the effect of dose rate. The increase in relative risk from myeloid leukaemia for an increase in average dose rate of 1 mGyd(-1) was 1.8 (1.1-2.8) for 239Pu, 2.0 (1.4-2.9) for 241Am and 1.5 (0.8-2.7) for 233U. Significant increases in renal and hepatic carcinomas were also recorded in animals exposed to 233U and 241Am, respectively. Studies of the distribution of the nuclides within the skeleton, published separately, have shown differences in their retention in individual bones and within bone. The proportions of decays occurring near to endosteal bone surfaces and throughout bone marrow were in the order: 239Pu> 241Am>233U. CONCLUSIONS: For osteosarcoma, the relative effectiveness of the nuclides in terms of average bone dose, in the order 239Pu>241Am>233U, is consistent with the proportion of dose delivered near to endosteal surfaces. For myeloid leukaemia, the greater effectiveness of 239Pu and 241Am than 233U is consistent with their accumulation in marrow.
Asunto(s)
Americio/efectos adversos , Leucemia Mieloide Aguda/etiología , Neoplasias Inducidas por Radiación/etiología , Osteosarcoma/etiología , Plutonio/efectos adversos , Radioisótopos/efectos adversos , Uranio/efectos adversos , Animales , Huesos/efectos de la radiación , Relación Dosis-Respuesta en la Radiación , Femenino , Masculino , Ratones , Ratones Endogámicos CBA , Análisis de Regresión , Factores de Tiempo , Distribución TisularRESUMEN
PURPOSE: To study the temporal change in microdistribution of plutonium-239, americium-241 and uranium-233 in the mouse distal femur and to compare and combine calculated radiation doses with those obtained previously for the femoral shaft. Also, to relate doses to relative risks of osteosarcoma and acute myeloid leukaemia. MATERIALS AND METHODS: Computer-based image analysis of neutron-induced and alpha-track autoradiographs of sections of mouse femora was used to quantify the microdistribution of (239)Pu, (241)Am and (233)U from 1 to 448 days after intraperitoneal injection. Localized dose-rates and cumulative doses over this period were calculated for different regions of the marrow spaces in trabecular bone. The results were then combined with previous data for doses to the cortical marrow of the femoral shaft. A morphometric analysis of the distal femur was carried out. RESULTS: Initial deposition on endosteal surfaces and dose-rates near to the trabecular surfaces at 1 day were two to four times greater than corresponding results for cortical bone. Burial was most rapid for (233)U, about twice the rate in cortical bone. As in cortical bone, subsequent uptake into the marrow was seen for (239)Pu and (241)Am but not (233)U. Cumulative doses to 448 days for different regions of trabecular marrow were greater than corresponding values for cortical marrow for each radionuclide. Combined doses reflected the greater overall volume of cortical marrow. CONCLUSIONS: Cumulative radiation doses to the 10 microm thick band of marrow adjacent to all endosteal surfaces were in the ratio of approximately 7:3:1 for (239)Pu:(241)Am:(233)U. This ratio is not inconsistent with observed incidences of osteosarcoma induction by the three nuclides. Analysis of doses to different depths of marrow, however, showed that although ratios were probably not significantly different to that for a 10 microm depth, better correlations with osteosarcomagenic risk were obtained with 20-40 microm depths. For acute myeloid leukaemia, the closest relationship between relative risk and doses was obtained by considering only the central 5-10% of marrow, which gave a dose ratio of approximately 12:11:1 for (239)Pu:(241)Am:(233)U respectively.
Asunto(s)
Americio/toxicidad , Médula Ósea/efectos de la radiación , Plutonio/toxicidad , Uranio/toxicidad , Americio/farmacocinética , Animales , Autorradiografía , Médula Ósea/metabolismo , Relación Dosis-Respuesta en la Radiación , Fémur/metabolismo , Fémur/efectos de la radiación , Humanos , Leucemia Mieloide Aguda/etiología , Masculino , Ratones , Ratones Endogámicos CBA , Neoplasias Inducidas por Radiación/etiología , Osteosarcoma/etiología , Plutonio/farmacocinética , Radiometría , Factores de Riesgo , Distribución Tisular , Uranio/farmacocinéticaRESUMEN
PURPOSE: To analyse the temporal change in microdistribution of 239Pu, 241Am and 233U in mouse femur and to compare the calculated radiation doses with regions of the bone marrow thought to contain target cells for osteosarcoma and leukaemia with relative risk for those diseases. MATERIALS AND METHODS: Neutron-induced and alpha-track autoradiographs were prepared from femora of the CBA/H mouse that had been injected with 40 kBq kg(-1) radionuclide between 1 and 448 days previously. Computer-based image analysis of the autoradiographs was performed and dosimetric methods applied to obtain radiation dose-rates to different regions of the marrow cavity. RESULTS: Initially each radionuclide deposited on endosteal and periosteal bone surfaces; 241Am was additionally deposited on vascular canal surfaces. Redistribution resulted in 233U being incorporated into bone, while 239Pu and 241Am showed transfer into both bone volume and marrow. Accumulation in the central marrow peaked at 112-224 days post-injection, but subsequently was cleared by 448 days. Cumulative doses to both osteosarcomagenic and myeloid leukaemogenic target cell regions showed the trend 239Pu > 241Am > 233U. CONCLUSIONS: Calculation of cumulative doses to a 10-microm layer of marrow adjacent to bone surfaces appears to be a suitable predictor for risk of osteosarcoma. Risks of myeloid leukaemia in the mouse are better predicted by considering the central marrow as the target region rather than average dose to all marrow.
Asunto(s)
Americio/farmacocinética , Fémur/metabolismo , Plutonio/farmacocinética , Uranio/farmacocinética , Partículas alfa , Animales , Autorradiografía , Médula Ósea/metabolismo , Femenino , Procesamiento de Imagen Asistido por Computador , Inyecciones Intraperitoneales , Masculino , Ratones , Ratones Endogámicos CBA , Neutrones , Radiometría , Factores de Riesgo , Factores de TiempoRESUMEN
With DTPA as a comparison, the siderophore analogue code named 3,4,3-LIHOPO has been tested for its ability to remove 238Pu and 241Am from rats after their inhalation or intravenous injection as nitrate. The most effective treatment regimen for inhaled Pu was the repeated administration of 30 mumol kg-1 3,4,3-LIHOPO. By 7 days after exposure, the Pu contents of the lungs and total body were reduced respectively to 2 and 4% of those in untreated animals. These values were six and three times less than when DTPA was administered using the same protocol. For inhaled Am, 3,4,3-LIHOPO and DTPA were considered equally effective, the lung and total body contents being reduced respectively to 13 and 10% of those in controls. Some animals showed slight degenerative changes in the liver and proximal tubules of the kidneys after the repeated administration of 30 mumol kg-1 of 3,4,3-LIHOPO; however these changes were less marked than after DTPA treatment. After the intravenous injection of Pu, the most effective regimen was the single administration of 3 mumol kg-1 3,4,3-LIHOPO. The body content at 7 days was reduced to 7% controls compared with 19% after the repeated administration of 30 mumol kg-1 DTPA. At a dosage of 30 mumol kg-1, 3,4,3-LIHOPO was less effective owing to the higher retention of Pu in the liver. With repeated dosages of 30 mumol kg-1 3,4,3-LIHOPO was more effective than DTPA for the decorporation of Am; the body contents were 16 and 31% of those in controls respectively. Importantly, the body content was still reduced to 28% of control after a single administration of 3 mumol kg-1. The ligand 3,4,3-LIHOPO, which is also superior to other siderophore analogues, could represent a most significant development in the decorporation of Pu and Am.
Asunto(s)
Americio/farmacocinética , Amidas/farmacología , Compuestos Aza/farmacología , Ácido Pentético/farmacología , Plutonio/farmacocinética , Piridonas/farmacología , Administración por Inhalación , Americio/administración & dosificación , Animales , Carga Corporal (Radioterapia) , Femenino , Inyecciones Intravenosas , Riñón/efectos de la radiación , Hígado/metabolismo , Hígado/efectos de la radiación , Plutonio/administración & dosificación , RatasRESUMEN
The pure carboxylated catechoyl amide LICAM(C) and the calcium and zinc salts of diethylenetriaminepenta-acetic acid (DTPA), were tested for efficacy for removing 238Pu and 241Am from rats after inhalation of the nitrate or intravenous injection of the citrate. The results were compared with the efficacy of methylated LICAM(C) used in previous experiments. It was shown that: (1) after inhalation of 238Pu nitrate, DTPA was far superior to pure LICAM(C); (2) after intravenous injection of 238Pu citrate, the infusion of DTPA plus LICAM(C) was only marginally more effective than DTPA alone; and (3) after inhalation or intravenous injection of 238Pu plus 241Am, the efficacy of pure LICAM(C) was only marginally more effective than the methylated form and neither form was effective for the decorporation of 241Am. It was concluded that DTPA, at present, remains the chelating agent of choice for treating persons accidentally contaminated with transportable forms of Pu and Am.
Asunto(s)
Americio/farmacocinética , Quelantes/uso terapéutico , Ácido Pentético/uso terapéutico , Plutonio/farmacocinética , Aerosoles , Americio/administración & dosificación , Animales , Cromatografía Líquida de Alta Presión , Femenino , Concentración de Iones de Hidrógeno , Inyecciones Intravenosas , Metilación , Nitratos , Plutonio/administración & dosificación , Ratas , Espermidina/uso terapéutico , Relación Estructura-Actividad , Distribución TisularRESUMEN
Groups of male and female CBA/H mice were given intraperitoneal injections of 40 kBq kg-1 of 239Pu, 241Am and 233U citrate solutions and the retention and distribution of the three radionuclides compared at times up to 448 days. Similar results were obtained for males and females and showed that: 1. Whole body retention at 448 days was very similar for 239Pu and 241Am, accounting for about 20% of injected activity for each nuclide; retention of 233U was much lower at about 3%. 2. The skeleton accounted for 85% or more of retained 239Pu, 241Am and 233U activity from 6 weeks after injection. 3. The greatest concentrations of each radionuclide were measured in the main body of the spine, limb girdles and ribs, with lowest concentrations in the paw bones, head bones and caudal vertebrae. The inhomogeneity of distribution was in the order Pu > U > Am; with a trend to more uniform activity with time. 4. Average bone doses to 448 days were calculated as about 1.6 and 1.7 Gy for 239Pu and 241Am, respectively, and 0.3 Gy for 233U, with ranges for individual bones of 0.7-3.0 Gy, 1.1-2.5 Gy and 0.1-0.6 Gy, respectively. Average liver doses to 448 days were calculated as about 0.9 Gy, 0.6 Gy and 0.007 Gy for 239Pu, 241Am and 233U respectively, whilst the dose to the kidney for 233U was about 0.1 Gy. 5. Autoradiographic studies of the distribution of the nuclides in the femur showed differences in their initial distribution and subsequent movement. Initially, concentrations of 239Pu were greater on endosteal than periosteal surfaces while 241Am distributed more evenly on bone surfaces. The initial deposition of 233U on all surfaces was uneven with concentrations probably on active surfaces. Burial of all three nuclides in areas of bone growth was observed. Transfer of activity to the marrow was greatest for 239Pu and least for 233U.
Asunto(s)
Plutonio/toxicidad , Uranio/toxicidad , Americio/metabolismo , Americio/toxicidad , Animales , Autorradiografía , Huesos/metabolismo , Femenino , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos CBA , Osteosarcoma/inducido químicamente , Plutonio/metabolismo , Uranio/metabolismoRESUMEN
Tiron (sodium 4,5-dihydroxybenzene-1,3-disulphonate) has been suggested as a possible antidote for acute uranium poisoning. In this study, the compound has been administered intraperitoneally to rats in dosages of 30, 300 or 1000 mumols kg-1 at 20, 60 and 180 min after the intratracheal instillation of uranyl nitrate. The amounts of uranium deposited in the lungs of rats were equivalent to intakes by workers of about 12 times the permitted daily limit of 2.5 mg. The average body content of uranium at 5 d after exposure were, respectively, about 100%, 78% and 65% of those in untreated animals. It is concluded that the administration of Tiron is of limited practical value for treatment of uranium exposures not greatly in excess of the permitted intake.
Asunto(s)
Sal Disódica del Ácido 1,2-Dihidroxibenceno-3,5-Disulfónico/farmacología , Uranio/orina , Animales , Etilenodiaminas/farmacología , Heces/química , Femenino , Ácido Pentético/farmacología , Ratas , Distribución Tisular , Uranio/farmacocinéticaRESUMEN
The efficacy of CaDTPA and ZnDTPA, the chelating agents of choice for several actinide elements, have been evaluated after the deposition of thorium in the rat lung in widely different amounts. The results showed that: 1. When the initial mass concentration of thorium simulated human exposure to four times the annual limits on intake for 232Th, the prompt (300 or 1000 mumol kg-1 body weight at 0.02 d) or repeated (30 or 300 mumol kg-1 body weight at 0.02, 0.25, 1,2,3 d) administration of CaDTPA were at best only moderately successful for enhancing the elimination of thorium. By 7 d after exposure, the body contents of thorium were, respectively, about 74%, 65%, 90% and 74% of those present in untreated animals. 2. When the mass concentration simulated 1.7 x 10(-3) times the annual limits on intake for 232Th, the efficacy of treatment was not increased appreciably despite the substantial reduction in mass. After the repeated administration of CaDTPA at doses of 30 and 300 mumol kg-1 using the protocol above, the body contents of thorium by 7 d were, respectively, 69% and 51% of those in untreated animals. 3. Under comparable conditions, the efficacy of ZnDTPA was less than CaDTPA. The results suggest that more effective chelating agents are needed for the treatment of workers exposed to water soluble thorium compounds.
Asunto(s)
Pulmón/metabolismo , Ácido Pentético/uso terapéutico , Compuestos de Torio , Torio/envenenamiento , Administración por Inhalación , Animales , Femenino , Inyecciones Intravenosas , Instilación de Medicamentos , Pulmón/efectos de los fármacos , Ratas , Torio/farmacocinética , Distribución TisularRESUMEN
This study has examined the efficacy of ZnDTPA administered in drinking water for removing 238Pu and 241Am from the rat after their simultaneous inhalation as nitrates; the dosage used was 95 mumol kg-1d-1. The continuous administration of ZnDTPA over a 14 d interval, commencing 1 h after exposure, reduced the lung and total body contents of 238Pu to, respectively, 11% and 18% of those in untreated rats; the corresponding values for 241Am were 11% and 14%. After the continuous administration of 95 mumol kg-1 from 4 d to 28 d post exposure, the lung and total body contents of 238Pu were, respectively, 5% and 16% of those in controls; the corresponding values for 241Am were 7% and 19%. Further reductions in the actinide contents of body tissues were found when treatment was extended to 52 d or 76 d. These regimens were as effective as twice weekly injections of 30 mumol kg-1 ZnDTPA commencing at 4 d. After the continuous administration of 95 mumol kg-1 d-1 for 72 d, some pathological changes to the gastrointestinal tract were observed but these were considered to be reparable. It was concluded that further work is required to evaluate the toxicity of the ligand and to establish the optimal treatment regimen.
Asunto(s)
Americio/farmacocinética , Quelantes/farmacología , Ácido Pentético/farmacología , Plutonio/farmacocinética , Administración por Inhalación , Administración Oral , Americio/administración & dosificación , Americio/sangre , Animales , Quelantes/administración & dosificación , Ingestión de Líquidos , Femenino , Inyecciones Intraperitoneales , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Tasa de Depuración Metabólica/efectos de los fármacos , Ácido Pentético/administración & dosificación , Ácido Pentético/toxicidad , Plutonio/administración & dosificación , Plutonio/sangre , Ratas , Ratas EndogámicasRESUMEN
The biokinetics of 239Pu and 241Am present in three dust samples obtained from Maralinga were investigated after their deposition in the rat lung. Results were used as an experimental basis for assessing the radiological implications for human exposure. The transfer rates of these actinides to blood in the various dusts differed by 50-fold. The most transportable forms were compatible with a material that had 25% class W and 75% class Y characteristics. The doses per unit intake for adults, children, and infants exposed to an aerosol of 5 microns AMAD were calculated to be, respectively, 0.059, 0.076, and 0.140 mSv Bq-1. The corresponding doses for the least transportable forms were the same as those calculated for a class Y compound, namely 0.036, 0.049, and 0.096 mSv Bq-1. The behavior of the actinides in humans was predicted by combining the transfer rates to blood with mechanical clearance data obtained after volunteers had inhaled 85Sr or 88Y labeled fused aluminosilicate particles. The results suggested that monitoring of 241Am in the chest could be used to advantage for assessing intakes incurred by workers involved with any further decontamination procedures but would be of little practical value for assessing inadvertent public exposure. The paper includes comments on the relevance of the 1990 ICRP recommendations and the proposed new dosimetric model for the respiratory tract.
Asunto(s)
Americio/farmacocinética , Polvo , Pulmón/metabolismo , Guerra Nuclear , Plutonio/farmacocinética , Ceniza Radiactiva , Administración por Inhalación , Americio/administración & dosificación , Americio/sangre , Animales , Femenino , Plutonio/administración & dosificación , Plutonio/sangre , Ratas , Australia del SurRESUMEN
Values for the absorption parameters were compared after inhalation or intratracheal instillation of 1.5 microm mass median aerodynamic diameter (MMAD) 233U3O8 particles into the lungs of HMT strain rats. The two sets of parameter values were similar, as were the calculated dose coefficients and predicted biokinetics for workers. Hence the inhalation and instillation techniques can probably both be used to generate values of the absorption parameters for U3O8.
Asunto(s)
Pulmón/metabolismo , Modelos Biológicos , Óxidos/administración & dosificación , Óxidos/farmacocinética , Radiometría/métodos , Compuestos de Uranio/administración & dosificación , Compuestos de Uranio/farmacocinética , Absorción , Administración por Inhalación , Contaminantes Radiactivos del Aire/farmacocinética , Contaminantes Radiactivos del Aire/orina , Animales , Simulación por Computador , Humanos , Exposición por Inhalación/análisis , Inyecciones Intravenosas , Tasa de Depuración Metabólica , Óxidos/orina , Dosis de Radiación , Ratas , Compuestos de Uranio/orinaRESUMEN
This study investigated the tissue distribution and excretion of uranium after its deposition as either the nitrate or bicarbonate in the three regions of the respiratory system of the rat. Results confirm the recommendations of ICRP that uranyl nitrate and bicarbonate should be treated as class D compounds; but imply that some of the parameters used in the ICRP lung model are not applicable to soluble uranium compounds.
Asunto(s)
Bicarbonatos/farmacocinética , Pulmón/metabolismo , Compuestos de Uranio , Uranio/farmacocinética , Animales , Femenino , Ratas , Ratas Endogámicas , Distribución Tisular , Nitrato de Uranilo/farmacocinéticaRESUMEN
Animal experiments have suggested that Puchel, a lipophilic derivative of DTPA may be of use in removing plutonium from humans after an accidental intake. This study reports toxicological findings in mice. After the administration of Puchel, as single or repeated doses of the pentasodium salt, an LD50/ld value of 530 +/- 44 mg kg-1 was obtained.
Asunto(s)
Ácido Pentético/análogos & derivados , Animales , Conducta Animal/efectos de los fármacos , Dosificación Letal Mediana , Masculino , Ratones , Ratones Endogámicos CBA , Ácido Pentético/toxicidad , Factores de TiempoRESUMEN
The effects of bronchopulmonary lavage with isotonic NaCl have been investigated in the hamster, and methods are described for separating pulmonary surfactant from cells in lavage fluid and for the quantitative isolation of surfactant from lung. It has been shown that hamsters almost invariably survived a lavage which consisted of ten successive washes each of 2 ml saline. This procedure removed about 80 per cent. of the total surfactant originally present and the surfactant content of the lung was restored to normal within 24 hr. The same procedure however removed at most only about 25 per cent. of the total number of macrophages in the lung and although a second lavage performed immediately after the first removed large numbers of macrophages, if a delay of several hours elapsed between the two lavages, the yield of macrophages was greatly reduced. The reasons for this behaviour are not understood, and it is likely to be one of the factors which limits the frequency with which pulmonary lavage can be repeated.
Asunto(s)
Pulmón/fisiología , Macrófagos/fisiología , Surfactantes Pulmonares/metabolismo , Irrigación Terapéutica , Animales , Bronquios , Recuento de Células , Cricetinae , Femenino , Cinética , Pulmón/citología , Pulmón/metabolismo , Macrófagos/análisis , Masculino , Mesocricetus , Microscopía Electrónica , Fosfolípidos/análisisRESUMEN
Min (multiple intestinal neoplasia) mice carry a mutant allele of the murine Apc (adenomatous polyposis coli) locus and are predisposed to intestinal adenoma formation in the intestinal tract. Early studies have shown complete loss of function of Apc by whole chromosome loss on the tumor-sensitive C57BL/6J genetic background and in AKR x B6 F1 hybrids. Gamma-radiation-induced chromosomal losses focus the critical region on wt Apc, but because of the limited number of polymorphic markers used, no other critical regions of loss on chromosome 18 were identified. Using intestinal tumors arising spontaneously and induced by X-rays in CBA/H x C57BL/6J F1 hybrid mice and high-resolution microsatellite loss of heterozygosity (LOH) techniques, we provide mapping data for wt Apc loss, which confirms and extends earlier observations. In addition, high-frequency loss events at the Dpc4 locus were found in both spontaneous and radiation-induced tumors. These data identified LOH of Dpc4 as a critical secondary event following complete functional loss of Apc. LOH across the Trp53 genomic region of chromosome 11 was not observed. No LOH was recorded for the Mom1 candidate gene Pla2g2a or for 9 out of 10 polymorphic markers from the Mom1 genomic region on murine chromosome 4. One marker mapping distal to Pla2g2a showed LOH in a small minority of spontaneous tumors. These data support the contention that Mom1 does not act as a classical tumor suppressor. Overall, our data indicates a significant role for Dpc4 mutation in intestinal tumor progression in the mouse and provides further evidence for the importance of interstitial chromosome losses in radiation tumorigenesis.